1. Up front

   Up Front 23 May 2018 Pages: 1493 - 1494

   

2. Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review

   • P. Monica Lind
   • Lars Lind

   Review Open access 09 May 2018 Pages: 1495 - 1502

   

3. Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies

   • Guntram Schernthaner
   • Marie Helene Schernthaner-Reiter

   Review Open access 07 February 2018 Pages: 1503 - 1516

   

4. Spouses, social networks and other upstream determinants of type 2 diabetes mellitus

   • Joreintje D. Mackenbach
   • Nicole R. den Braver
   • Joline W. J. Beulens

   Commentary Open access 13 April 2018 Pages: 1517 - 1521

   

5. Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME®

   • Bernard Zinman
   • Silvio E. Inzucchi
   • on behalf of the EMPA-REG OUTCOME® investigators

   Short Communication 30 April 2018 Pages: 1522 - 1527

   

6. Community-based pre-pregnancy care programme improves pregnancy preparation in women with pregestational diabetes

   • Jennifer M. Yamamoto
   • Deborah J. F. Hughes
   • Helen R. Murphy

   Article Open access 09 May 2018 Pages: 1528 - 1537

   

7. Persistence of abnormalities in white matter in children with type 1 diabetes

   • Larry A. Fox
   • Tamara Hershey
   • for the Diabetes Research in Children Network (DirecNet)

   Article 13 April 2018 Pages: 1538 - 1547

   

8. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial

   • Julia Otten
   • Andreas Stomby
   • Tommy Olsson

   Article Open access 26 April 2018 Pages: 1548 - 1559

   

9. Plasma branched chain/aromatic amino acids, enriched Mediterranean diet and risk of type 2 diabetes: case-cohort study within the PREDIMED Trial

   • Miguel Ruiz-Canela
   • Marta Guasch-Ferré
   • Miguel A. Martínez-González

   Article 16 April 2018 Pages: 1560 - 1571

   

10. Spousal cardiometabolic risk factors and incidence of type 2 diabetes: a prospective analysis from the English Longitudinal Study of Ageing

    • Jannie Nielsen
    • Adam Hulman
    • Daniel R. Witte

    Article 08 March 2018 Pages: 1572 - 1580

    

11. Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial

    • Paul Welsh
    • Naomi Rankin
    • Naveed Sattar

    Article Open access 04 May 2018 Pages: 1581 - 1591

    

12. Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates

    • Francesco Zaccardi
    • Nafeesa N. Dhalwani
    • Kamlesh Khunti

    Article Open access 01 May 2018 Pages: 1592 - 1602

    

13. Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand

    • Mohanraj Krishnan
    • Tanya J. Major
    • Tony R. Merriman

    Article 02 May 2018 Pages: 1603 - 1613

    

14. Patterns of differential gene expression in a cellular model of human islet development, and relationship to type 2 diabetes predisposition

    • Marta Perez-Alcantara
    • Christian Honoré
    • Martijn van de Bunt

    Article Open access 19 April 2018 Pages: 1614 - 1622

    

15. SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients

    • Else M. Balke
    • Simke Demeester
    • Frans K. Gorus

    Article 20 April 2018 Pages: 1623 - 1632

    

16. A proinflammatory CD4⁺ T cell phenotype in gestational diabetes mellitus

    • Angela Sheu
    • Yixian Chan
    • Sue Mei Lau

    Article 24 April 2018 Pages: 1633 - 1643

    

17. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12

    • Peter Achenbach
    • Mohammed I. Hawa
    • on behalf of the Action LADA consortium

    Short Communication Open access 04 April 2018 Pages: 1644 - 1649

    

18. Abnormal islet sphingolipid metabolism in type 1 diabetes

    • Laurits J. Holm
    • Lars Krogvold
    • Karsten Buschard

    Article Open access 18 April 2018 Pages: 1650 - 1661

    

19. Evaluation of anti-insulin receptor antibodies as potential novel therapies for human insulin receptoropathy using cell culture models

    • Gemma V. Brierley
    • Kenneth Siddle
    • Robert K. Semple

    Article Open access 27 April 2018 Pages: 1662 - 1675

    

20. The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes

    • Joel T. Dunn
    • Pratik Choudhary
    • Stephanie A. Amiel

    Article Open access 12 May 2018 Pages: 1676 - 1687

    

21. Correction to: Clinically meaningful and lasting HbA_1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis

    • Krishnarajah Nirantharakumar
    • Nuredin Mohammed
    • Parth Narendran

    Correction 25 April 2018 Pages: 1688 - 1689